ANAVEX LIFE SCIENCES CORP.: 10-Q filed 2016-05-11
What ANAVEX LIFE SCIENCES CORP. reported in its quarterly report filed 2016-05-11 (fiscal Q2 2016): 23 published measures, 66 facts as tagged in accession 0001615774-16-005331.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-05-11
- Fiscal period
- fiscal Q2 2016
- Accession
- 0001615774-16-005331 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ANAVEX LIFE SCIENCES CORP. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 12,115,249 | USD | |
| At 2015-09-30 | 15,469,913 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 2,432,064 | USD | |
| At 2015-09-30 | 2,660,910 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 9,683,185 | USD | |
| At 2015-09-30 | 12,809,003 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | -2,030,801 | USD | 91 |
| 2015-10-01 to 2016-03-31 | -5,985,310 | USD | 183 |
| 2015-01-01 to 2015-03-31 | -1,724,859 | USD | 90 |
| 2014-10-01 to 2015-03-31 | -2,511,577 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | -69,266,765 | USD | |
| At 2015-09-30 | -63,281,455 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 35,214,793 | shares | 91 |
| 2015-10-01 to 2016-03-31 | 34,589,957 | shares | 183 |
| 2015-01-01 to 2015-03-31 | 14,326,945 | shares | 90 |
| 2014-10-01 to 2015-03-31 | 13,609,473 | shares | 182 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 35,214,793 | shares | 91 |
| 2015-10-01 to 2016-03-31 | 34,589,957 | shares | 183 |
| 2015-01-01 to 2015-03-31 | 14,326,945 | shares | 90 |
| 2014-10-01 to 2015-03-31 | 13,609,473 | shares | 182 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | -0.06 | USD/shares | 91 |
| 2015-10-01 to 2016-03-31 | -0.17 | USD/shares | 183 |
| 2015-01-01 to 2015-03-31 | -0.12 | USD/shares | 90 |
| 2014-10-01 to 2015-03-31 | -0.18 | USD/shares | 182 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | -0.06 | USD/shares | 91 |
| 2015-10-01 to 2016-03-31 | -0.17 | USD/shares | 183 |
| 2015-01-01 to 2015-03-31 | -0.12 | USD/shares | 90 |
| 2014-10-01 to 2015-03-31 | -0.18 | USD/shares | 182 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-10-01 to 2016-03-31 | 17,615 | USD | 183 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 755 | USD | |
| At 2015-09-30 | 1,252 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-10-01 to 2016-03-31 | 1,048,710 | USD | 183 |
| 2014-10-01 to 2015-03-31 | 31,544 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 12,114,494 | USD | |
| At 2015-09-30 | 15,468,661 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | -2,064 | USD | 91 |
| 2015-10-01 to 2016-03-31 | -4,206 | USD | 183 |
| 2015-01-01 to 2015-03-31 | -2,228 | USD | 90 |
| 2014-10-01 to 2015-03-31 | 74,781 | USD | 182 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 2,431,727 | USD | |
| At 2015-09-30 | 2,660,578 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 2,180,168 | USD | 91 |
| 2015-10-01 to 2016-03-31 | 6,712,602 | USD | 183 |
| 2015-01-01 to 2015-03-31 | 858,339 | USD | 90 |
| 2014-10-01 to 2015-03-31 | 1,629,017 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 1,327,393 | USD | 91 |
| 2015-10-01 to 2016-03-31 | 1,998,129 | USD | 183 |
| 2015-01-01 to 2015-03-31 | 407,146 | USD | 90 |
| 2014-10-01 to 2015-03-31 | 725,771 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 35,695,572 | shares | |
| At 2015-09-30 | 32,044,213 | shares |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | -2,030,801 | USD | 91 |
| 2015-10-01 to 2016-03-31 | -5,967,695 | USD | 183 |
| 2015-01-01 to 2015-03-31 | -1,724,859 | USD | 90 |
| 2014-10-01 to 2015-03-31 | -2,511,577 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 852,775 | USD | 91 |
| 2015-10-01 to 2016-03-31 | 4,714,473 | USD | 183 |
| 2015-01-01 to 2015-03-31 | 451,193 | USD | 90 |
| 2014-10-01 to 2015-03-31 | 903,246 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-10-01 to 2016-03-31 | 497 | USD | 183 |
| 2014-10-01 to 2015-03-31 | 498 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 149,367 | USD | 91 |
| 2015-10-01 to 2016-03-31 | 744,907 | USD | 183 |
| 2015-01-01 to 2015-03-31 | -866,520 | USD | 90 |
| 2014-10-01 to 2015-03-31 | -882,560 | USD | 182 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-10-01 to 2016-03-31 | 1,830 | USD | 183 |
Inspect the source
- Entity
- ANAVEX LIFE SCIENCES CORP. / CIK 0001314052
- Captured
- 2026-09-20T07:51:32.244Z
- SEC response SHA-256
58235b1aa01b2e3fa186f80cce94f8ff6bd171b1d8823aeeecb0ffde54d83b04
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001314052.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))